India drugmaker stocks exception in Asian rout

Last Updated: Thursday, September 3, 2015, 19:37

In Mumbai trading so far this year, Lupin Ltd has climbed 32 percent, Dr. Reddy`s 31 percent, Glenmark Pharmaceuticals 42 percent and Wockhardt 29 percent.

Glenmark receives USFDA nod for oral contraceptive drug

Last Updated: Wednesday, August 19, 2015, 11:47

"Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Drospirenone and Ethinyl Estradiol tablets USP, 3 mg/0.02 mg," the company said in a BSE filing.

Glenmark Q1 net up 3.29% at Rs 191 crore

Last Updated: Thursday, July 30, 2015, 18:27

Glenmark Pharmaceuticals on Thursday posted 3.29 percent rise in consolidated net profit at Rs 190.93 crore for the first quarter ended June 30, driven by sales in domestic as well as overseas markets.

US court rejects Glenmark's patent plea for Finacea

Last Updated: Tuesday, July 28, 2015, 23:25

Drug firm Glenmark's generic skin care drug that was under patent litigation infinges patent of Bayer, a US court has ruled.

Glenmark gets USFDA final nod for contraceptive tablets

Last Updated: Monday, June 15, 2015, 15:44

Glenmark Pharmaceuticals has received final nod from the US health regulator for generic oral contraceptive Levonorgestrel/Ethinyl Estradiol tablets and plans to commence shipping of the product immediately.

Glenmark gets final USFDA nod for psoriasis cream

Last Updated: Thursday, June 11, 2015, 14:20

Glenmark Pharma was today trading at Rs 867.35 in the afternoon trade on BSE, up 1.19 percent.

Glenmark gets USFDA nod for generic diabetes treatment drug

Last Updated: Friday, May 29, 2015, 12:49

Shares of Glenmark Pharmaceuticals were trading at Rs 874.75 per scrip in afternoon trade, up 2.04 percent from the previous close on the BSE.

Glenmark gets tentative USFDA nod to sell Rufinamide

Last Updated: Thursday, May 21, 2015, 12:54

Rufinamide is used to treat seizures caused by Lennox-Gastaut syndrome.

Glenmark issues over 1 cr shares to Aranda, raises Rs 945 cr

Last Updated: Tuesday, May 19, 2015, 21:29

Glenmark Pharmaceuticals has raised Rs 945 crore by issuing over 1 crore shares to Aranda Investments, an indirect subsidiary of Temasek Holdings.

FIIs can now invest up to 49% in Glenmark Pharma

Last Updated: Tuesday, May 19, 2015, 21:26

The Reserve Bank Tuesday allowed foreign institutional investors (FIIs) to buy up to 49 percent stake in homegrown drug major Glenmark Pharmaceuticals.